We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we address this and restore your personalized lists.
S&P Futures
5,178.50 +11.00 (+0.21%) Dow Futures
38,307.00 +69.00 (+0.18%) Nasdaq Futures
18,221.50 +42.25 (+0.23%) Russell 2000 Futures
2,030.10 +10.30 (+0.51%) Crude Oil
85.42 -0.24 (-0.28%) Gold
2,371.50 -2.60 (-0.11%)
After hours:
Chart Events
Performance Outlook
| Previous Close | 346.29 |
| Open | 342.90 |
| Bid | 340.70 x 1200 |
| Ask | 342.53 x 800 |
| Day's Range | 339.31 - 344.12 |
| 52 Week Range | 249.98 - 361.41 |
| Volume | |
| Avg. Volume | 1,264,238 |
| Market Cap | 130.14B |
| Beta (5Y Monthly) | 0.91 |
| PE Ratio (TTM) | 41.51 |
| EPS (TTM) | 8.24 |
| Earnings Date | Apr 30, 2024 |
| Forward Dividend & Yield | 3.20 (0.94%) |
| Ex-Dividend Date | Mar 27, 2024 |
| 1y Target Est | 369.62 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for SYK
Related Research
- Stryker CorporationWeekly Stock ListWe see what we believe are some great opportunities right now in Healthcare -- and we like the sector overall. Argus Director of Research Jim Kelleher, CFA, recently completed his quarterly sector review and raised Healthcare sector to Over-Weight from Market-Weight. The healthcare environment is undergoing rapid transitions, and we now see an unfolding period of significant promise and opportunity. Our newly-favored stance is based on resumption of deferred medical procedures and significant new quality-of-life drugs and treatments. The category is broad and has underperformed the S&P 500 over the past year. The Healthcare sector ETF (XLV) is up 15% over the past year compared to a gain of 31% for the S&P 500. We see opportunity here to pick up some steady companies, with big brands and solid financials. These companies are science-focused and enhance lives. They are innovators. In our list this week, we look across several subsectors within the Healthcare sector and pull out some leaders we like. These stocks also are included in our Focus List and Model Portfolios, as noted below.RatingFair ValueEconomic Moat28 days agoArgus Research
ZacksHologic's (HOLX) New Launches Aid, Macroeconomic Issues Ail
Hologic's (HOLX) Breast Health segment is gaining from a broad portfolio of solutions for breast cancer care, primarily in the burgeoning spaces of radiology, breast surgery, pathology and treatment.
- Zacks
Smith+Nephew (SNN) Expands in Australia With New Alliance
The latest partnership allows Smith+Nephew (SNN) to complement its existing implant range with the cutting-edge navigation technology of NAVBIT.
ZacksAlign Technology (ALGN) Up 20.5% YTD: Will the Rally Continue?
Investors are optimistic about Align Technology (ALGN) driven by geographic expansion and upbeat guidance.
ZacksBoston Scientific (BSX) Faces Rising Costs, Competition
With Boston Scientific (BSX) recording 40% of its sales from the international market, it remains highly exposed to currency fluctuations.
- Zacks
Here's Why You Should Retain Myriad Genetics (MYGN) Stock Now
Investors are optimistic about Myriad Genetics' (MYGN) strong solvency position and improvement in testing volume.
ZacksLabcorp's (LH) Strategic Alliances Aid Amid Macroeconomic Woes
Labcorp (LH) is investing in innovation and technology that supports diagnostic and drug development testing for various diseases such as cancer and Alzheimer's.
- Zacks
Bruker (BRKR) Introduces Magnet Technology for NMR Adoption
Bruker's (BRKR) latest novel technology facilitates the widespread application of NMR in academic basic and clinical research.
ZacksHere's Why Investors Should Retain Integra (IART) Stock Now
Integra's (IART) strong focus on portfolio optimization and international expansion bolsters investors' confidence in the stock.
ZacksThermo Fisher (TMO) Launches TSX Universal Series ULT Freezers
Thermo Fisher's (TMO) new ENERGY STAR-certified TSX Universal Series ULT Freezers deliver tighter temperature control and faster recovery times.
ZacksAbbott (ABT) Faces Low Testing Demand, Currency Headwinds
Abbott's (ABT) core laboratory diagnostics business is gaining strength on the continued success of the Alinity suite of diagnostics instruments, along with a broad test menu offering.
Morningstar Rating
Rating
Fair Value
Economic Moat
People Also Watch
| Symbol | Last Price | Change | % Change |
|---|---|---|---|
| MDT Medtronic plc | |||
| BDX Becton, Dickinson and Company | |||
| TMO Thermo Fisher Scientific Inc. | |||
| DHR Danaher Corporation | |||
| BSX Boston Scientific Corporation |
Similar to SYK
| Symbol | Last Price | Change | % Change |
|---|---|---|---|
| BSX Boston Scientific Corporation | |||
| ZBH Zimmer Biomet Holdings, Inc. | |||
| MDT Medtronic plc | |||
| ABT Abbott Laboratories | |||
| EW Edwards Lifesciences Corporation |
Analyst Price Targets (24)
Upgrades & Downgrades
| Maintains | TD Cowen: Buy to Buy | 4/11/2024 | |
| Maintains | Evercore ISI Group: Outperform to Outperform | 4/4/2024 | |
| Maintains | Citigroup: Buy to Buy | 4/3/2024 | |
| Reiterates | RBC Capital: Outperform to Outperform | 2/15/2024 | |
| Maintains | Citigroup: Buy to Buy | 1/31/2024 | |
| Maintains | Truist Securities: Hold to Hold | 1/31/2024 |
Company Profile
1941 Stryker Way
Portage, MI 49002
United States
269 385 2600
https://www.stryker.com
Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 52,000
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
